Nomura Holdings’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.05M Hold
100,000
– – 0.01% 574
2026
Q1
$8.01M Sell
100,000
-116,200
-54% -$9.58M 0.02% 486
2025
Q4
$18.4M Buy
216,200
+116,200
+116% +$9.54M 0.02% 340
2025
Q3
$7.78M Buy
+100,000
New +$7.81M 0.01% 605
2024
Q2
– Sell
-501,300
Closed -$47.9M – 1832
2024
Q1
$47.9M Buy
+501,300
New +$42.1M 0.12% 128
2022
Q4
– Sell
-9,800
Closed -$810K – 1562
2022
Q3
$810K Buy
+9,800
New +$943K ﹤0.01% 1000

Other funds holding EW

Nomura Holdings's EW Position: Q2 2026 in Review

Nomura Holdings increased its Edwards Lifesciences (EW) stake by 949% in Q2 2026, buying an estimated $2.45M and bringing the position to 32,343 shares worth $2.93M. The position accounts for ﹤0.01% of the portfolio, ranked #967.

Nomura Holdings first reported a position in EW in Q2 2013 and has held it in 36 quarters since. The position peaked at $29.2M in Q1 2024. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Nomura Holdings held 32,343 shares of Edwards Lifesciences worth $2.93M as of Q2 2026.
  • Nomura Holdings bought 29,261 Edwards Lifesciences shares in Q2 2026, an estimated $2.45M.
  • Edwards Lifesciences made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #967 holding.
  • Nomura Holdings first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 36 quarters since.
  • Nomura Holdings's Edwards Lifesciences position peaked at $29.2M in Q1 2024.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.